Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Walt Disney Co (DIS) vs Nuwellis Inc (NUWE) Price & Performance

Walt Disney CoTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Walt Disney Co vs Nuwellis Inc — how do they compare? Walt Disney Co trades at $95.8 (market cap $166.48B), while Nuwellis Inc trades at $3.16 (market cap $1.17M). The key difference: Walt Disney Co is far larger — about 142290.6× Nuwellis Inc's market cap, and Walt Disney Co pays a 1.56% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

DISNUWE
Market Cap
$166.48B$1.17M
Volume
7,546,013
Sector
MediaTechnology
52-Week High
$122.94$558.26
52-Week Low
$92.40$2.80
Enterprise Value
$208.16B-$636.97K
Dividend Yield
1.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Walt Disney Co

Disney (DIS) trades at $96.01, up 0.4% today, with a bearish technical signal but strong fundamentals including three consecutive quarterly EPS beats. Revenue grew to $94.43B in 2025 with net income surging to $12.40B. The stock shows a P/E of 15.34 and P/S of 1.77, trading below the consensus price target of $125.60. Recent news highlights advertising opportunities from major events like the Super Bowl, though box office performance for new Star Wars film raises concerns.

Outlook remains positive with analyst consensus at Buy (61.9%) and a 31% upside to target, driven by earnings momentum and theme park investments. Risks include regulatory disputes with the FCC, streaming competition, and film profitability. Cash flow trends show operational strength but negative net flows from high investing activity.

Nuwellis Inc

NUWE trades at $2.80, down 7.89% in the last session, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025 despite $8.27M revenue, reflecting negative profit margins and cash flow challenges. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026, alongside a CEO transition to Mike McCormick effective June 30, 2026.

Outlook remains high-risk due to persistent losses and cash burn, though analyst consensus is split evenly between Buy and Hold. Key risks include execution in revenue growth and reliance on financing. Upside depends on successful commercialization of Aquadex therapy and FDA label expansion for pediatric patients.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Walt Disney Co

The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.

Read more on DIS

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE